These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 11182598)
1. The design of combinatorial libraries using properties and 3D pharmacophore fingerprints. Beno BR; Mason JS Drug Discov Today; 2001 Mar; 6(5):251-258. PubMed ID: 11182598 [TBL] [Abstract][Full Text] [Related]
3. New 4-point pharmacophore method for molecular similarity and diversity applications: overview of the method and applications, including a novel approach to the design of combinatorial libraries containing privileged substructures. Mason JS; Morize I; Menard PR; Cheney DL; Hulme C; Labaudiniere RF J Med Chem; 1999 Aug; 42(17):3251-64. PubMed ID: 10464012 [TBL] [Abstract][Full Text] [Related]
4. Selecting optimally diverse compounds from structure databases: a validation study of two-dimensional and three-dimensional molecular descriptors. Matter H J Med Chem; 1997 Apr; 40(8):1219-29. PubMed ID: 9111296 [TBL] [Abstract][Full Text] [Related]
5. How diverse are diversity assessment methods? A comparative analysis and benchmarking of molecular descriptor space. Koutsoukas A; Paricharak S; Galloway WR; Spring DR; Ijzerman AP; Glen RC; Marcus D; Bender A J Chem Inf Model; 2014 Jan; 54(1):230-42. PubMed ID: 24289493 [TBL] [Abstract][Full Text] [Related]
6. DIVSEL and COMPLIB--strategies for the design and comparison of combinatorial libraries using pharmacophoric descriptors. Pickett SD; Luttmann C; Guerin V; Laoui A; James E J Chem Inf Comput Sci; 1998; 38(2):144-50. PubMed ID: 9538516 [TBL] [Abstract][Full Text] [Related]
7. Combining pharmacophore fingerprints and PLS-discriminant analysis for virtual screening and SAR elucidation. Askjaer S; Langgård M J Chem Inf Model; 2008 Mar; 48(3):476-88. PubMed ID: 18281962 [TBL] [Abstract][Full Text] [Related]
9. Enhancing the hit-to-lead properties of lead optimization libraries. Pickett SD; McLay IM; Clark DE J Chem Inf Comput Sci; 2000 Mar; 40(2):263-72. PubMed ID: 10761127 [TBL] [Abstract][Full Text] [Related]
10. 3-D pharmacophores in drug discovery. Mason JS; Good AC; Martin EJ Curr Pharm Des; 2001 May; 7(7):567-97. PubMed ID: 11375769 [TBL] [Abstract][Full Text] [Related]
11. Mini-fingerprints detect similar activity of receptor ligands previously recognized only by three-dimensional pharmacophore-based methods. Xue L; Stahura FL; Godden JW; Bajorath J J Chem Inf Comput Sci; 2001; 41(2):394-401. PubMed ID: 11277728 [TBL] [Abstract][Full Text] [Related]
12. Measuring diversity: experimental design of combinatorial libraries for drug discovery. Martin EJ; Blaney JM; Siani MA; Spellmeyer DC; Wong AK; Moos WH J Med Chem; 1995 Apr; 38(9):1431-6. PubMed ID: 7739001 [TBL] [Abstract][Full Text] [Related]
16. Pharmacophore modeling in drug discovery and development: an overview. Khedkar SA; Malde AK; Coutinho EC; Srivastava S Med Chem; 2007 Mar; 3(2):187-97. PubMed ID: 17348856 [TBL] [Abstract][Full Text] [Related]
19. Optimization and visualization of molecular diversity of combinatorial libraries. Hassan M; Bielawski JP; Hempel JC; Waldman M Mol Divers; 1996 Oct; 2(1-2):64-74. PubMed ID: 9238635 [TBL] [Abstract][Full Text] [Related]
20. New methodology for profiling combinatorial libraries and screening sets: cleaning up the design process with HARPick. Good AC; Lewis RA J Med Chem; 1997 Nov; 40(24):3926-36. PubMed ID: 9397173 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]